Duloxetine in the Treatment of Melancholic Depression
NCT00191685
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Depressive Disorder, Major
Interventions
DRUG:
duloxetine
Sponsor
Eli Lilly and Company